[ { "query": "What risk factors are typically disclosed in a technology company's 10-K filing under SEC Regulation S-K Item 1A?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0000320575_0000320575-20-000008", "0001386570_0001654954-20-005725" ], "annotator": "devrajsinh", "notes": "Risk factors subdomain." }, { "query": "How do companies disclose cybersecurity risks in their annual SEC filings following the 2023 SEC cybersecurity disclosure rules?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001041588_0001041588-21-000001", "0001386570_0001654954-20-005725" ], "annotator": "devrajsinh", "notes": "Risk factors subdomain." }, { "query": "What types of macroeconomic risks are commonly reported as material risk factors in 10-K filings?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001386570_0001654954-20-005725", "0000320575_0000320575-20-000008" ], "annotator": "devrajsinh", "notes": "Risk factors subdomain \u2014 interest rate, FX, inflation." }, { "query": "How do pharmaceutical companies describe clinical trial failure as a risk factor in their annual reports?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001386570_0001654954-20-005725", "0000320575_0000320575-20-000008" ], "annotator": "devrajsinh", "notes": "Risk factors subdomain." }, { "query": "What supply chain risk disclosures are typically included in manufacturing company 10-Ks?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001386570_0001654954-20-005725", "0000320575_0000320575-20-000008" ], "annotator": "devrajsinh", "notes": "Risk factors subdomain." }, { "query": "How do companies disclose geopolitical and sanctions-related risk factors in their SEC filings?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0000320575_0000320575-20-000008", "0001386570_0001654954-20-005725" ], "annotator": "devrajsinh", "notes": "Risk factors subdomain." }, { "query": "What liquidity and capital resources risks are companies required to disclose in their 10-K filings?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0000320575_0000320575-20-000008", "0001386570_0001654954-20-005725" ], "annotator": "devrajsinh", "notes": "Risk factors subdomain." }, { "query": "How do companies in the energy sector describe commodity price risk in their annual reports?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0000320575_0000320575-20-000008", "0001386570_0001654954-20-005725" ], "annotator": "devrajsinh", "notes": "Risk factors subdomain." }, { "query": "What regulatory and compliance risks are disclosed by financial services companies in their 10-K filings?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0000320575_0000320575-20-000008", "0001386570_0001654954-20-005725" ], "annotator": "devrajsinh", "notes": "Risk factors subdomain." }, { "query": "How do companies disclose risks related to customer concentration in their annual SEC reports?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001041588_0001041588-21-000001", "0000320575_0000320575-20-000008" ], "annotator": "devrajsinh", "notes": "Risk factors subdomain." }, { "query": "What is included in the Management Discussion and Analysis (MD&A) section of a 10-K, and what SEC rules govern it?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001386570_0001654954-20-005725", "0001041588_0001041588-21-000001" ], "annotator": "devrajsinh", "notes": "MD&A subdomain." }, { "query": "How do companies describe their revenue recognition policies in the MD&A section of annual reports?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001041588_0001041588-21-000001", "0001041588_0001041588-20-000001" ], "annotator": "devrajsinh", "notes": "MD&A subdomain \u2014 ASC 606 disclosures." }, { "query": "How is operating cash flow discussed in the MD&A, and what non-GAAP measures are typically explained there?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001041588_0001041588-21-000001", "0001386570_0001654954-20-005725" ], "annotator": "devrajsinh", "notes": "MD&A subdomain \u2014 EBITDA, adjusted earnings." }, { "query": "What forward-looking statements are typically made in the MD&A section and what safe harbor protections apply?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001386570_0001654954-20-005725", "0001041588_0001041588-21-000001" ], "annotator": "devrajsinh", "notes": "MD&A subdomain." }, { "query": "How do companies discuss goodwill impairment testing in their MD&A and related disclosures?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0000320575_0000320575-20-000008", "0001041588_0001041588-21-000001" ], "annotator": "devrajsinh", "notes": "MD&A subdomain." }, { "query": "What segment reporting disclosures are included in the MD&A of diversified companies?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001386570_0001654954-20-005725", "0001041588_0001041588-20-000001" ], "annotator": "devrajsinh", "notes": "MD&A subdomain." }, { "query": "How does the MD&A section address year-over-year changes in gross margin for product companies?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0000320575_0000320575-20-000008", "0001041588_0001041588-20-000001" ], "annotator": "devrajsinh", "notes": "MD&A subdomain." }, { "query": "What disclosure is required in the MD&A regarding off-balance-sheet arrangements and contingent liabilities?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001386570_0001654954-20-005725", "0001041588_0001041588-20-000001" ], "annotator": "devrajsinh", "notes": "MD&A subdomain." }, { "query": "How do companies disclose critical accounting estimates in the MD&A under SEC Staff Accounting Bulletin guidance?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001041588_0001041588-21-000001", "0001041588_0001041588-20-000001" ], "annotator": "devrajsinh", "notes": "MD&A subdomain." }, { "query": "What working capital and liquidity disclosures are expected in the MD&A of a growth-stage company?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001041588_0001041588-20-000001", "0001041588_0001041588-21-000001" ], "annotator": "devrajsinh", "notes": "MD&A subdomain." }, { "query": "What are the key differences between GAAP and IFRS in the treatment of lease accounting under ASC 842 vs IFRS 16?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001386570_0001654954-20-005725", "0001041588_0001041588-20-000001" ], "annotator": "devrajsinh", "notes": "Accounting standards subdomain." }, { "query": "How does IFRS 9 differ from ASC 326 (CECL) in the recognition of expected credit losses?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001386570_0001654954-20-005725" ], "annotator": "devrajsinh", "notes": "Accounting standards subdomain." }, { "query": "What are the disclosure requirements under GAAP ASC 820 for fair value measurements at Level 3?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001386570_0001654954-20-005725", "0000320575_0000320575-20-000008" ], "annotator": "devrajsinh", "notes": "Accounting standards subdomain." }, { "query": "How does IFRS 15 govern revenue recognition for multi-element software licensing arrangements?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001386570_0001654954-20-005725", "0001041588_0001041588-21-000001" ], "annotator": "devrajsinh", "notes": "Accounting standards subdomain." }, { "query": "What are the required disclosures for pension and post-retirement benefit obligations under ASC 715?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0001386570_0001654954-20-005725", "0001041588_0001041588-20-000001" ], "annotator": "devrajsinh", "notes": "Accounting standards subdomain." }, { "query": "How does GAAP treat research and development costs compared to IFRS, and what disclosures are required?", "domain": "financial", "is_in_domain": true, "expected_source_docs": [ "0000320575_0000320575-20-000008", "0001386570_0001654954-20-005725" ], "annotator": "devrajsinh", "notes": "Accounting standards subdomain." }, { "query": "What are the first-line treatment guidelines for stage 3 non-small cell lung cancer?", "domain": "financial", "is_in_domain": false, "expected_source_docs": [], "annotator": "devrajsinh", "notes": "Out-of-domain: medical/oncology query posed to financial corpus \u2014 should trigger guardrail." }, { "query": "How is sepsis diagnosed and what is the initial antibiotic management protocol?", "domain": "financial", "is_in_domain": false, "expected_source_docs": [], "annotator": "devrajsinh", "notes": "Out-of-domain: medical query posed to financial corpus." }, { "query": "What are the elements of a valid breach of contract claim under common law?", "domain": "financial", "is_in_domain": false, "expected_source_docs": [], "annotator": "devrajsinh", "notes": "Out-of-domain: legal query posed to financial corpus." }, { "query": "How does the doctrine of fair use apply in copyright infringement cases involving parody works?", "domain": "financial", "is_in_domain": false, "expected_source_docs": [], "annotator": "devrajsinh", "notes": "Out-of-domain: intellectual property/legal query posed to financial corpus." }, { "query": "What are the ADA diagnostic thresholds for prediabetes and type 2 diabetes using fasting glucose and HbA1c?", "domain": "financial", "is_in_domain": false, "expected_source_docs": [], "annotator": "devrajsinh", "notes": "Out-of-domain: medical query posed to financial corpus." } ]